23 October 2016

Sinclair IS Pharma cuts loss 

22/09/11 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today


Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info


Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

STM completes smart deal 21/10/16

Specialist pensions administrator STM has completed the acquisition of London and Colonial which was announced at the time of last month’s interims. The deal is attractively priced, being earnings enhancing and offering scope to release regulatory capital.

Elecosoft acquires an ICON  17/10/16

Elecosoft has acquired software developer ICON for £2.4 million. This should fit well with Elecosoft’s German Esign unit which also supplies 3D visualisation software

Genedrive launches first test in India 12/10/16

Genedrive has undergone some significant changes over the last year. There’s a new management team in place and £6 million of fresh equity was raised over the summer to fund the commercialisation push.

Miton remains upbeat about small caps 11/10/16

The latest news in the UK fund management industry is the transatlantic merger of Henderson and Janus. So where does this leave managers at the other end of the scale like Miton? 

Sales still elusive at Fox Marble  07/10/16

It’s fair to say Fox Marble is one of the most intriguing yet frustrating shares on the market. It holds out the prospect of big dividends once the cash starts flowing from its marble quarries in Kosovo; but so far sales have been painfully slow to build.

ScS sitting comfortably 04/10/16

Sofa and flooring retailer ScS has produced a strong set of figures for the year ended in July. Revenues grew 15 per cent with double digit gains in all product categories and sales channels. According to CEO David Knight the consumer continued shopping throughout the year, including the periods before and after the referendum.

More News